EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Investigating the Antifibrotic Effects of β-Citronellol on a TGF-β1-Stimulated LX-2 Hepatic Stellate Cell Model

Watunyoo Buakaew iD, Sucheewin Krobthong iD, Yodying Yingchutrakul iD, Pachuen Potup, Yordhathai Thongsri iD, Krai Daowtak iD, Antonio Ferrante iD, Kanchana Usuwanthim iD

Biomolecules · 2024

DOI: 10.3390/biom14070800 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2024. Verfasst von Watunyoo Buakaew und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Faculty of Medicine, Srinakharinwirot University, Bangkok 10110, Thailand. Hauptthemen laut MEDLINE: Hepatic Stellate Cells, Liver Cirrhosis, Transforming Growth Factor beta1, Acyclic Monoterpenes. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Thailand Science Research and Innovation, and Naresuan University, Reinventing University Program 2023, The Ministry of Higher Education, Science, Research and Innovation (MHESI), Thailand, Reinventing University Program 2023, The Ministry of Higher Education, Science, Research and Innovation (MHESI).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liver fibrosis, a consequence of chronic liver damage or inflammation, is characterized by the excessive buildup of extracellular matrix components. This progressive condition significantly raises the risk of severe liver diseases like cirrhosis and hepatocellular carcinoma. The lack of approved therapeutics underscores the urgent need for novel anti-fibrotic drugs. Hepatic stellate cells (HSCs), key players in fibrogenesis, are promising targets for drug discovery. This study investigated the anti-fibrotic potential of Citrus hystrix DC. (KL) and its bioactive compound, β-citronellol (β-CIT), in a human HSC cell line (LX-2). Cells exposed to TGF-β1 to induce fibrogenesis were co-treated with crude KL extract and β-CIT. Gene expression was analyzed by real-time qRT-PCR to assess fibrosis-associated genes (ACTA2, COL1A1, TIMP1, SMAD2). The release of matrix metalloproteinase 9 (MMP-9) was measured by ELISA. Proteomic analysis and molecular docking identified potential signaling proteins and modeled protein–ligand interactions. The results showed that both crude KL extract and β-CIT suppressed HSC activation genes and MMP-9 levels. The MAPK signaling pathway emerged as a potential target of β-CIT. This study demonstrates the ability of KL extract and β-CIT to inhibit HSC activation during TGF-β1-induced fibrogenesis, suggesting a promising role of β-CIT in anti-hepatic fibrosis therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatic Stellate CellsLiver CirrhosisTransforming Growth Factor beta1Acyclic MonoterpenesHumansActinsAntifibrotic AgentsCell LineCollagen Type ICollagen Type I, alpha 1 ChainMatrix Metalloproteinase 9Molecular Docking SimulationSmad2 ProteinTissue Inhibitor of Metalloproteinase-1

Stichwörter der Autor:innen

Citrus hystrix DC.hepatic stellate cellliver fibrosismolecular dockingproteomic analysisβ-citronellol

Substanzen

ACTA2 protein, humanActinsAntifibrotic AgentsCOL1A1 protein, humanCollagen Type ICollagen Type I, alpha 1 ChainMatrix Metalloproteinase 9MMP9 protein, humanSmad2 ProteinSMAD2 protein, human

Autor:innen und Institutionen

  • Department of Microbiology, Faculty of Medicine, Srinakharinwirot University, Bangkok 10110, Thailand.
  • Cellular and Molecular Immunology Research Unit (CMIRU), Faculty of Allied Health Sciences, Naresuan University, Phitsanulok 65000, Thailand.
  • Center of Excellence in Natural Products Chemistry (CENP), Department of Chemistry, Faculty of Science, Chulalongkorn University, Bangkok 10330, Thailand.
  • National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency (NSTDA), Pathum Thani 12120, Thailand.
  • Department of Immunopathology, South Australia (SA) Pathology, Women's and Children's Hospital, Adelaide, SA 5006, Australia.
  • The Adelaide Medical School, The School of Biological Science and the Robinson Research Institute, University of Adelaide, Adelaide, SA 5000, Australia.

ORCID-Profile: Watunyoo Buakaew, Sucheewin Krobthong, Yodying Yingchutrakul, Yordhathai Thongsri, Krai Daowtak, Antonio Ferrante, Kanchana Usuwanthim

Förderung

  • Thailand Science Research and Innovation, and Naresuan University
  • Reinventing University Program 2023, The Ministry of Higher Education, Science, Research and Innovation (MHESI), Thailand
  • Reinventing University Program 2023, The Ministry of Higher Education, Science, Research and Innovation (MHESI)

Zitieren

APA

Buakaew, W., Krobthong, S., Yingchutrakul, Y., Potup, P., Thongsri, Y., Daowtak, K., Ferrante, A., & Usuwanthim, K. (2024). Investigating the Antifibrotic Effects of β-Citronellol on a TGF-β1-Stimulated LX-2 Hepatic Stellate Cell Model. Biomolecules. https://doi.org/10.3390/biom14070800

Vancouver

Buakaew W, Krobthong S, Yingchutrakul Y, Potup P, Thongsri Y, Daowtak K, et al. Investigating the Antifibrotic Effects of β-Citronellol on a TGF-β1-Stimulated LX-2 Hepatic Stellate Cell Model. Biomolecules. 2024. doi:10.3390/biom14070800

BibTeX
@article{Buakaew2024,
  author = {Buakaew, Watunyoo and Krobthong, Sucheewin and Yingchutrakul, Yodying and Potup, Pachuen and Thongsri, Yordhathai and Daowtak, Krai and Ferrante, Antonio and Usuwanthim, Kanchana},
  title = {Investigating the Antifibrotic Effects of β-Citronellol on a TGF-β1-Stimulated LX-2 Hepatic Stellate Cell Model},
  journal = {Biomolecules},
  year = {2024},
  doi = {10.3390/biom14070800}
}
Kostenlos starten →